Insider Transactions in Q2 2023 at Pacira Bio Sciences, Inc. (PCRX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
Roy Winston Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,950
+17.31%
|
-
|
|
Jun 14
2023
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
6,366
-7.44%
|
$241,908
$38.33 P/Share
|
|
Jun 14
2023
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+25.61%
|
-
|
|
Jun 14
2023
|
David M Stack CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+14.92%
|
-
|
|
Jun 14
2023
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
6,467
-20.31%
|
$239,279
$37.03 P/Share
|
|
Jun 14
2023
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,950
+25.59%
|
-
|
|
Jun 14
2023
|
Gary W Pace Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+1.24%
|
-
|
|
Jun 14
2023
|
Charles A. Reinhart Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,000
+17.43%
|
-
|
|
Jun 14
2023
|
Mark Froimson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+18.46%
|
-
|
|
Jun 14
2023
|
Daryl Gaugler Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+24.07%
|
-
|
|
Jun 14
2023
|
Paul J Hastings Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+17.49%
|
-
|
|
Jun 14
2023
|
Mark A. Kronenfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+8.28%
|
-
|
|
Jun 14
2023
|
Laura Brege Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+13.55%
|
-
|
|
Jun 14
2023
|
Christopher Christie Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,775
+25.23%
|
-
|
|
Jun 08
2023
|
Mark A. Kronenfeld Director |
SELL
Open market or private sale
|
Direct |
15,000
-45.6%
|
$555,000
$37.04 P/Share
|
|
Jun 08
2023
|
Mark A. Kronenfeld Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+31.32%
|
$435,000
$29.9 P/Share
|
|
Jun 07
2023
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,357
-6.1%
|
$50,209
$37.87 P/Share
|
|
Jun 07
2023
|
Roy Winston Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,857
-4.3%
|
$68,709
$37.87 P/Share
|
|
Jun 07
2023
|
Charles A. Reinhart Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,371
-3.92%
|
$50,727
$37.87 P/Share
|
|
Jun 07
2023
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
616
-3.13%
|
$22,792
$37.87 P/Share
|
|
Jun 07
2023
|
Jonathan Slonin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
490
-1.33%
|
$18,130
$37.87 P/Share
|
|
Jun 07
2023
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
5,326
-3.35%
|
$197,062
$37.87 P/Share
|
|
Jun 07
2023
|
Dennis Mc Loughlin Chief Customer Officer |
SELL
Open market or private sale
|
Direct |
1,057
-2.7%
|
$39,109
$37.87 P/Share
|
|
Jun 07
2023
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
1,099
-3.62%
|
$40,663
$37.87 P/Share
|
|
Jun 07
2023
|
Ronald J. Ellis Jr. Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,162
-3.62%
|
$42,994
$37.87 P/Share
|
|
Jun 07
2023
|
Daryl Gaugler Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,047
-4.64%
|
$38,739
$37.87 P/Share
|
|
Jun 06
2023
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,301
-5.52%
|
$49,438
$38.99 P/Share
|
|
Jun 06
2023
|
Roy Winston Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,779
-3.95%
|
$67,602
$38.99 P/Share
|
|
Jun 06
2023
|
Charles A. Reinhart Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,236
-3.41%
|
$46,968
$38.99 P/Share
|
|
Jun 06
2023
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
591
-2.92%
|
$22,458
$38.99 P/Share
|
|
Jun 06
2023
|
Jonathan Slonin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
471
-1.26%
|
$17,898
$38.99 P/Share
|
|
Jun 06
2023
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
5,058
-3.08%
|
$192,204
$38.99 P/Share
|
|
Jun 06
2023
|
Dennis Mc Loughlin Chief Customer Officer |
SELL
Open market or private sale
|
Direct |
1,014
-2.52%
|
$38,532
$38.99 P/Share
|
|
Jun 06
2023
|
Anthony Molloy Chief Lgl & Compliance Officer |
SELL
Open market or private sale
|
Direct |
4,521
-25.99%
|
$171,798
$38.55 P/Share
|
|
Jun 06
2023
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
1,054
-3.36%
|
$40,052
$38.99 P/Share
|
|
Jun 06
2023
|
Ronald J. Ellis Jr. Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,114
-3.36%
|
$42,332
$38.99 P/Share
|
|
Jun 06
2023
|
Daryl Gaugler Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,005
-4.26%
|
$38,190
$38.99 P/Share
|
|
Jun 05
2023
|
Anthony Molloy Chief Lgl & Compliance Officer |
SELL
Open market or private sale
|
Direct |
2,267
-11.53%
|
$86,146
$38.28 P/Share
|
|
Jun 05
2023
|
Daryl Gaugler Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,000
-4.07%
|
$38,000
$38.74 P/Share
|
|
Jun 05
2023
|
Paul J Hastings Director |
SELL
Open market or private sale
|
Direct |
580
-8.08%
|
$22,040
$38.34 P/Share
|
|
Jun 05
2023
|
Laura Brege Director |
SELL
Open market or private sale
|
Direct |
600
-5.91%
|
$22,800
$38.74 P/Share
|
|
May 31
2023
|
Daryl Gaugler Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,500
-9.23%
|
$97,500
$39.08 P/Share
|
|
May 31
2023
|
Daryl Gaugler Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+8.51%
|
$85,000
$34.0 P/Share
|
|
May 15
2023
|
Paul J Hastings Director |
SELL
Open market or private sale
|
Direct |
7,000
-49.37%
|
$287,000
$41.85 P/Share
|
|
May 15
2023
|
Paul J Hastings Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+33.05%
|
$203,000
$29.9 P/Share
|
|
May 11
2023
|
Gary W Pace Director |
SELL
Open market or private sale
|
Direct |
5,015
-3.47%
|
$205,615
$41.78 P/Share
|
|
May 11
2023
|
Gary W Pace Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.61%
|
$203,000
$29.9 P/Share
|
|
Apr 03
2023
|
Laura Brege Director |
SELL
Open market or private sale
|
Direct |
7,000
-40.82%
|
$280,000
$40.72 P/Share
|
|
Apr 03
2023
|
Laura Brege Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+28.99%
|
$203,000
$29.9 P/Share
|